Showing 19,161 - 19,180 results of 20,793 for search '"Therapy"', query time: 0.10s Refine Results
  1. 19161

    A Retrospective on Nuclear Receptor Regulation of Inflammation: Lessons from GR and PPARs by Min-Dian Li, Xiaoyong Yang

    Published 2011-01-01
    “…A better understanding of the molecular mechanism by which nuclear receptors inhibit proinflammatory signaling pathways will enable novel therapies to treat chronic inflammation.…”
    Get full text
    Article
  2. 19162

    Radioembolization in the Treatment of Neuroendocrine Tumor Metastases to the Liver by Martin Vyleta, Douglas Coldwell

    Published 2011-01-01
    “…On an outpatient basis, radioembolization can be utilized from early line to salvage phases, in various combinations with systemic therapies. Review of available data shows encouraging safety and efficacy profiles for the intraarterial application of 90Y for the treatment of mNETs of the liver. …”
    Get full text
    Article
  3. 19163

    A Case Report with Severe Thrombocytopenia Induced by Axitinib by Ulkuhan I. Koksal, Janeiro Valle Goffin, Brian Lewis, Oliver A. Sartor, Elizaveta Belyaeva, Francisco Socola, Pedro C. Barata

    Published 2020-01-01
    “…In this report, we presented a rare case of grade 4 axitinib-induced thrombocytopenia, not observed with other antiangiogenic therapies. We discuss the differential diagnostic work-up, the necessary multidisciplinary approach, and the successful management of the case.…”
    Get full text
    Article
  4. 19164

    Inflammatory bowel diseases during the COVID-19 pandemic by Edyta Derda, Edyta Szymańska, Magda Sokolek, Jarosław Kierkuś

    Published 2024-09-01
    “…Inflammatory bowel diseases (IBD) are chronic, incurable conditions of digestive system with unknown aetiology, but one of the causes is disordered immune response. Medical therapies most frequently used in IBD are immune suppressing or modifying with the rising use of biologic treatment. …”
    Get full text
    Article
  5. 19165

    Progress on the Prevention of Esophageal Stricture after Endoscopic Submucosal Dissection by Peina Shi, Xiaoyun Ding

    Published 2018-01-01
    “…With the improvement of current therapies, ESD can be more widely utilized as a minimally invasive treatment with minimal complications.…”
    Get full text
    Article
  6. 19166
  7. 19167
  8. 19168
  9. 19169

    SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation by Ryan T. Wagner, Ryan A. Hlady, Xiaoyu Pan, Liguo Wang, Sungho Kim, Xia Zhao, Louis Y. El Khoury, Shafiq Shaikh, Jian Zhong, Jeong-Heon Lee, Jolanta Grembecka, Tomasz Cierpicki, Thai H. Ho, Keith D. Robertson

    Published 2025-02-01
    “…Conclusions These findings unify genome-wide screening approaches with the latest genetic and pharmacologic modeling methodologies to reveal an entirely novel epigenetic approach to individualize therapies against a challenging loss-of-function SETD2 mutation in cancer.…”
    Get full text
    Article
  10. 19170

    Exploring purine analogues as inhibitors against Katanin, a microtubule severing enzyme using molecular modeling approach by Vibhuti Saxena, Pruthanka Patil, Purva Khodke, Bajarang Vasant Kumbhar

    Published 2024-12-01
    “…Inhibiting katanin’s function could potentially hinder the uncontrolled growth of cancerous cells, making it an attractive target for novel anti-cancer therapies. Previous studies have shown that purine-based compounds exhibit a strong affinity for microtubule-severing enzymes. …”
    Get full text
    Article
  11. 19171

    Unveiling the novel role of circadian rhythms in sepsis and septic shock: unexplored implications for chronotherapy by Stewart D. Ramsay, Stewart D. Ramsay, Stewart D. Ramsay, Marni A. Nenke, Marni A. Nenke, Emily J. Meyer, Emily J. Meyer, David J. Torpy, David J. Torpy, Richard L. Young, Richard L. Young, Richard L. Young, Richard L. Young

    Published 2025-02-01
    “…Despite knowledge of how circadian rhythms change in these grave conditions, very little research has been undertaken on the use of these therapies in support of sepsis management. This review details the circadian disruptions associated with sepsis and septic shock, the influence they have on morbidity and mortality, and the potential clinical benefits of circadian-modulating therapies.…”
    Get full text
    Article
  12. 19172

    An overview of potential cardioprotective benefits of xanthophylls in atherosclerosis: an evidence-based review by Yuting Su, Feng Chen, Jiehua Chen, Mingfu Wang

    Published 2024-07-01
    “…Xanthophylls, one of the main groups of carotenoids, have been proposed as preventive agents or adjunct therapies to prevent and slow the progression of atherosclerosis due to their cardioprotective properties. …”
    Get full text
    Article
  13. 19173

    STATE INSTITUTIONS IN THE FIGHT AGAINST THE NEGATIVE EFFECTS OF GAMBLING IN POLAND by Zygmunt DUDEK

    Published 2024-12-01
    “…It focuses on the Fiscal Administration, which controls this area of activity, and the National Health Fund, which, through financial outlays and therapies provided, helps the addicted to overcome their addiction to gambling. …”
    Get full text
    Article
  14. 19174

    Tissue-Derived Stem and Progenitor Cells by Leora J. Tesche, David A. Gerber

    Published 2010-01-01
    “…Lastly, the challenges of clinical therapies will be discussed as it applies to these unique cell populations.…”
    Get full text
    Article
  15. 19175

    P53 and PIK3CA Mutations in KRAS/HER2 Negative Ovarian Intestinal-Type Mucinous Carcinoma Associated with Mature Teratoma by Sarah Bouri, Philippe Simon, Nicky D’Haene, Xavier Catteau, Jean-Christophe Noël

    Published 2020-01-01
    “…Our data suggest that these mucinous carcinoma variants probably present an extremely complex molecular biology profile that should be known in the future to stratify therapeutic outcomes and potential targeted therapies, particularly in recurrent disease.…”
    Get full text
    Article
  16. 19176

    Update in the Early Management and Reperfusion Strategies of Patients with Acute Ischemic Stroke by Aldo A. Mendez, Edgar A. Samaniego, Sunil A. Sheth, Sudeepta Dandapat, David M. Hasan, Kaustubh S. Limaye, Bradley J. Hindman, Colin P. Derdeyn, Santiago Ortega-Gutierrez

    Published 2018-01-01
    “…The paradigms on prehospital care, reperfusion therapies, and postreperfusion management of patients with AIS continue to evolve. …”
    Get full text
    Article
  17. 19177

    Relapsed Mantle Cell Lymphoma Presenting as “Sister Mary Joseph Nodule” by Jennifer E. Vaughn, Ajay K. Gopal

    Published 2010-01-01
    “…This clinical course is characteristic of the mantle cell form of non-hodgkin's lymphoma and illustrates a need to seek out more effective therapies.…”
    Get full text
    Article
  18. 19178

    Recent Advances in Carbon Nanotubes for Nervous Tissue Regeneration by Carlos Redondo-Gómez, Rocío Leandro-Mora, Daniela Blanch-Bermúdez, Christopher Espinoza-Araya, David Hidalgo-Barrantes, José Vega-Baudrit

    Published 2020-01-01
    “…CNTs still represent strong candidates for use in therapies of neurodegenerative pathologies and spinal cord injuries.…”
    Get full text
    Article
  19. 19179

    REVIEW – DIGITAL TECHNOLOGIES IN DENTAL IMPLANT PLANNING by Chikh Al Sagha Sama, Cristea Ioana, Curelariu Nura, Agop-Forna Doriana, Davidescu Alexandra, Norina Forna

    Published 2024-06-01
    “…The success of implant therapies depends on the precision of implant placement to effectively support prosthetic outcomes that optimize form and function. …”
    Get full text
    Article
  20. 19180

    Connections and Unmet Needs: Severe Asthma Biologics and Osteoporosis by Fabiana Furci, Marco Umberto Scaramozzino, Giuseppe Rocco Talesa, Corrado Pelaia

    Published 2025-01-01
    “…With the use of new, available biologic therapies for asthma, perhaps even anticipating the times of their use in therapeutic management, in the current guidelines and with targeted strategies of prevention it may be possible to improve asthma management, preventing some comorbidities, such as osteoporosis.…”
    Get full text
    Article